RCM Healthcare Services for Infectious Disease Practices

RCM medical billing is the broader financial process surrounding patient services, from registration and eligibility through documentation, coding, claims submission, payment posting, denial resolution, and accounts receivable follow-up. Medical billing is one part of RCM. For infectious disease practices, RCM may also involve OPAT, infusion, drug claims, authorization, buy-and-bill, and coverage agreement considerations.

Revenue cycle management can include referral intake, eligibility and benefits verification, prior authorization, documentation and coding review, charge capture, claim scrubbing, submission, rejection clearing, payment reconciliation, denial appeals, underpayment review, A/R follow-up, and contract compliance. In infectious disease, the workflow may also need to account for infusion administration, specialty drugs, OPAT courses, and medical-versus-pharmacy benefit rules.

No. Medical billing generally focuses on preparing, submitting, and following up on claims. RCM covers the wider financial workflow before, during, and after billing, including eligibility, authorization, documentation, coding, charge capture, payment reconciliation, denials, underpayments, A/R, and payer agreements. Billing is therefore a component of RCM rather than a complete substitute for it.

Infectious disease practices may combine cognitive visits with infusion, OPAT, drug acquisition, hospital consults, and contracted services. Each area can create distinct documentation, authorization, coding, reimbursement, and collection issues. A structured RCM review helps practices see where revenue is delayed, lost, or left uncollected and connects those gaps to workflow, payer, or operational causes.

An RCM workflow review can examine the path from referral to final payment. Areas may include documentation, coding, eligibility, prior authorization, drug and infusion billing, claims submission, denials, underpayments, A/R follow-up, payer contracts, and hospital coverage agreements. The resulting guidance can prioritize issues according to the practice’s own service lines, processes, and financial information.

Yes. Revenue leakage analysis looks for income that was not captured, billed, reimbursed, or collected as expected. Examples may include under-leveled visits, missing drug or administration charges, incorrect fee schedule application, unit or NDC mismatches, unpursued balances, and services delivered under agreements that do not clearly provide reimbursement. Findings can be traced to their operational source.

Practices can categorize denials and payment variances by payer, service type, provider, and root cause. Review areas may include authorization, medical-versus-pharmacy benefit confusion, drug and administration coding, documentation, fee schedule application, units, and NDC information. Payment reconciliation compares expected reimbursement with posted payment and helps identify disputes or recurring process problems.

The resources are intended for infectious disease physicians, independent infectious disease practices, infectious disease group leaders, and medical practice administrators. They can support users evaluating revenue streams, launching or reviewing OPAT and infusion services, adding providers, examining collections, or understanding how operational decisions affect financial sustainability. Users can apply their own practice information rather than relying on generalized assumptions.